Patents by Inventor Juluri Suresh

Juluri Suresh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS USEFUL AS CCR9 MODULATORS
    Publication number: 20180230098
    Abstract: The present invention relates to compounds useful as CCR9 modulators, to compositions containing them, to methods of making them, and to methods of using them. In particular, the present invention relates to compounds capable of modulating the function of the CCR9 receptor by acting as partial agonists, antagonists or inverse agonists. Such compounds may be useful to treat, prevent or ameliorate a disease or condition associated with CCR9 activation, including inflammatory and immune disorder diseases or conditions such as inflammatory bowel diseases (IBD).
    Type: Application
    Filed: April 13, 2018
    Publication date: August 16, 2018
    Applicant: Norgine B.V.
    Inventors: Rajagopal Bakthavatchalam, Manas Kumar Basu, Ajit Kumar Behera, Chandregowda Venkateshappa, Christopher Alexander Hewson, Sanjay Venkatachalapathi Kadnur, Sarkis Barret Kalindjian, Bheemashankar Kulkarni, Rohit Saxena, Juluri Suresh, Vellarkad Viswanathan, Mohd Zainuddin, Akila Parvathy Dharshinis, Rajenda Kristam
  • Compounds useful as CCR9 modulators
    Patent number: 9969687
    Abstract: The present invention relates to compounds useful as CCR9 modulators, to compositions containing them, to methods of making them, and to methods of using them. In particular, the present invention relates to compounds capable of modulating the function of the CCR9 receptor by acting as partial agonists, antagonists or inverse agonists. Such compounds may be useful to treat, prevent or ameliorate a disease or condition associated with CCR9 activation, including inflammatory and immune disorder diseases or conditions such as inflammatory bowel diseases (IBD).
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: May 15, 2018
    Assignee: Norgine B.V.
    Inventors: Rajagopal Bakthavatchalam, Manas Kumar Basu, Ajit Kumar Behera, Chandregowda Venkateshappa, Christopher Alexander Hewson, Sanjay Venkatachalapathi Kadnur, Sarkis Barret Kalindjian, Bheemashankar Kulkarni, Rohit Saxena, Juluri Suresh, Vellarkad Viswanathan, Mohd Zainuddin, Akila Parvathy Dharshinis, Rajenda Kristam
  • COMPOUNDS USEFUL AS CCR9 MODULATORS
    Publication number: 20170001959
    Abstract: The present invention relates to compounds useful as CCR9 modulators, to compositions containing them, to methods of making them, and to methods of using them. In particular, the present invention relates to compounds capable of modulating the function of the CCR9 receptor by acting as partial agonists, antagonists or inverse agonists. Such compounds may be useful to treat, prevent or ameliorate a disease or condition associated with CCR9 activation, including inflammatory and immune disorder diseases or conditions such as inflammatory bowel diseases (IBD).
    Type: Application
    Filed: December 22, 2014
    Publication date: January 5, 2017
    Applicant: Norgine B.V.
    Inventors: Rajagopal Bakthavatchalam, Manas Kumar Basu, Ajit Kumar Behera, Chandregowda Venkateshappa, Christopher Alexander Hewson, Sanjay Venkatachalapathi Kadnur, Sarkis Barret Kalindjian, Bheemashankar Kulkarni, Rohit Saxena, Juluri Suresh, Vellarkad Viswanathan, Mohd Zainuddin, Akila Parvathy Dharshinis, Rajenda Kristam
  • BENZENE SULFONAMIDES AS CCR9 INHIBITORS
    Publication number: 20170002011
    Abstract: The present invention relates to compounds useful as CCR9 modulators, to compositions containing them, to methods of making them, and to methods of using them. In particular, the present invention relates to compounds capable of modulating the function of the CCR9 receptor by acting as partial agonists, antagonists or inverse agonists. Such compounds may be useful to treat, prevent or ameliorate a disease or condition associated with CCR9 activation, including inflammatory and immune disorder diseases or conditions such as inflammatory bowel diseases (IBD).
    Type: Application
    Filed: December 22, 2014
    Publication date: January 5, 2017
    Applicant: Norgine B.V.
    Inventors: Rajagopal Bakthavatchalam, Manas Kumar Basu, Ajit Kumar Behera, Chandregowda Venkateshappa, Christopher Alexander Hewson, Sanjay Venkatachalapathi Kadnur, Sarkis Barret Kalindjian, Bheemashankar Kulkarni, Rohit Saxena, Juluri Suresh, Vellarkad Viswanathan, Mohd Zainuddin, Akila Parvathy Dharshinis, Rajenda Kristam